Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

AEVIS VICTORIA Aktie 47863410 / CH0478634105

03.11.2025 07:00:19

AEVIS VICTORIA SA (AEVS.SW) – Continued revenue growth in the third quarter of 2025

AEVIS VICTORIA SA / Key word(s): 9 Month figures
AEVIS VICTORIA SA (AEVS.SW) – Continued revenue growth in the third quarter of 2025

03-Nov-2025 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 LR

Fribourg, 3 November 2025

AEVIS VICTORIA SA (AEVS.SW) – Continued revenue growth in the third quarter of 2025

Consolidated growth of 18.2%, driven by the Healthcare and Hospitality divisions. Adjusted organic growth of 2.6%.

AEVIS VICTORIA SA (AEVIS) achieved consolidated gross revenue of CHF 899.2 million in the first nine months of 2025, compared to CHF 761.0 million in the same period of 2024, representing total growth of 18.2%. Net revenue amounted to CHF 789.9 million (3Q2024: CHF 668.6 million), up 18.1%, including adjusted organic growth of 1.5%.

Healthcare: sustained growth and successful integration of new entities
With its 21 hospitals and its outpatient centers, Swiss Medical Network generated gross revenue of CHF 722.6 million (3Q2024: CHF 594.9 million), up 21.5%. Adjusted organic growth reached 3.3%, supported by the expansion of the outpatient network and the full integration of Spital Zofingen, CentroMedico in Ticino, and several medical practices in German-speaking Switzerland. Swiss Medical Network is continuing its expansion in integrated care, with the extension of the integrated care model to a third region, Aare Netz – the first in German-speaking Switzerland – on 1 January 2026.

Viva Health: Attractive premiums in all cantons within the integrated care regions
VIVA Health, the alternative basic insurance product developed in collaboration with insurer Visana, is entering its third year with the lowest premiums on the market in most categories and cantons. Viva is available in the Jura Arc, Ticino, and Zofingen/Aarau regions.

Hospitality: positive momentum maintained
MRH Switzerland AG, the group's hotel division managed by Michel Reybier Hospitality, generated gross revenue of CHF 157.4 million (3Q2024: CHF 151.6 million), up 3.8%. Organic growth was supported by excellent performance across all establishments. The winter season, starting on 12 December 2025, looks promising, as Switzerland continues to strengthen its appeal as a travel destination. The hotel portfolio has remained unchanged at eleven properties.

Real Estate: strong contribution driven by apartment sales in Zermatt
The Real Estate division, represented by Swiss Hotel Properties SA, recorded revenue of CHF 36.1 million (3Q2024: CHF 24.0 million), up 50.5%. This increase was mainly due to the sale of apartments in Zermatt, around one-third of which have already been sold. The remaining units will be marketed by the end of the winter season (1Q2026), further supporting the division’s revenue in the next quarter.

Strategic options under review
AEVIS VICTORIA is currently exploring various strategic options for its subsidiaries, particularly Swiss Medical Network and Infracore, to support their long-term development. Swiss Medical Network aims to cover all regions where it operates with its integrated care offering and with Viva, the alternative basic insurance product developed with Visana. In this context, AEVIS plans to welcome new strategic shareholders and intends to reduce its participation in Swiss Medical Network in order to strengthen the independence of the Swiss integrated care group. In parallel, Infracore is exploring various opportunities to open up its capital base, potentially including a listing, to meet the growing demand for sale-and-leaseback solutions in the public and private hospital market in Switzerland.

For further information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey, prb@dynamicsgroup.ch, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32
Séverine Van der Schueren, svanderschueren@aevis.com, +41 (0) 79 635 04 10

AEVIS VICTORIA SA – Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS's main shareholdings are Swiss Medical Network Holding SA (76.3%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, MRH Switzerland AG, a luxury hotel group managing eleven hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW).
www.aevis.com.



End of Inside Information

2222138  03-Nov-2025 CET/CEST

Analysen zu AEVIS VICTORIA SA

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Kommt 2025 der grosse KI-Crash? Tim Schäfer über Nvidia, OpenAI & die Parallelen zu 1929

Könnte der aktuelle KI-Boom an den Börsen in einen Crash münden – ähnlich wie 1929 oder zur Dotcom-Blase? 📉💻

In diesem spannenden Gespräch mit Tim Schäfer sprechen wir über Parallelen zum historischen Börsencrash, die massive Überbewertung vieler Tech- und KI-Aktien wie Nvidia, Palantir oder Microsoft – und was das für Langfristanleger bedeutet. Ist der Hype finanziell überhaupt noch tragbar? Wie positionieren sich Insider und Grossinvestoren wie Warren Buffett oder Peter Thiel?

💬 Welche Risiken birgt der aktuelle KI-Hype?
💬 Was sagen Insiderverkäufe und Bewertungen über die Marktlage?
💬 Wie sollte man sich als Privatanleger jetzt aufstellen?

Ein Interview für alle, die sich fragen: Ist das noch Wachstum oder schon Wahnsinn?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Kommt 2025 der grosse KI-Crash? Tim Schäfer über Nvidia, OpenAI & die Parallelen zu 1929

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’237.09 19.93 SBGBHU
Short 13’524.37 13.68 S8FBOU
Short 14’034.06 8.79 SJLB4U
SMI-Kurs: 12’772.55 25.11.2025 17:30:00
Long 12’207.42 19.47 SK3BMU
Long 11’943.68 13.91 SETB4U
Long 11’438.06 8.97 SU9BIU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com